|
|
Cytomegalovirus (CMV)
The Basics
- Cytomegalovirus (CMV) (October 2007)
To read PDF, click here
From Project Inform
- Cytomegalovirus (CMV) (August 15, 2006)
From AIDS Treatment Data Network
- Cytomegalovirus and HIV (May 2006)
From HIV InSite
- Cytomegalovirus (CMV) (February 26, 2005)
To read PDF, click here
From AIDS InfoNet
- What is CMV? (June 10, 2003)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- Cytomegalovirus Retinitis in 2003 (May 2003)
Even with the advent of HAART, CMV disease continues to be an important clinical problem in people living with HIV.
In Hopkins HIV Report
- Cytomegalovirus (CMV) and You (April 2003)
A guide for people with HIV infection.
From U.S. Centers for Disease Control and Prevention
- Patient/Doctor Q&A: CMV, Cervical Cancer, MRSA and Low Platelets (September 2002)
To read PDF, click here
In HIV Treatment ALERTS!, from The Center for AIDS
- Save Your Sight: Eye Disease and HIV (December 2001/January 2002)
In Positive Living, from AIDS Project Los Angeles
- Eye Diagram (May 1998)
From U.S. National Institutes of Health
- Eye Problems (Summer 1997)
In Women Alive Newsletter, from Women Alive
- CMV Background (April/May 1997)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Cidofovir Reaches Drugstores (August 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- CMV Retinitis and Treatment: CME Course on World Wide Web (July 5, 1996)
In AIDS Treatment News, from AIDS Treatment News
- How to Help Yourself: AIDS-Related CMV (January 1994)
From U.S. National Institute of Allergy and Infectious Diseases
- AIDS, HIV, and the Eye
From American Academy of Ophthalmology
- The Amsler Grid and Other Self-Tests for CMV Reinitis
From AIDS Research Information Center
Prevention
Treatment
- Cidofovir (Vistide, HPMPC) (August 15, 2006)
From AIDS Treatment Data Network
- Ganciclovir Implants (Vitrasert) (August 15, 2006)
From AIDS Treatment Data Network
- Oral Ganciclovir (Cytovene) (August 15, 2006)
From AIDS Treatment Data Network
- Cytomegalovirus Disease (December 17, 2004)
A chapter from "Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents" guidelines.
To read PDF, click here
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
- An Overview of Ganciclovir (Cytovene, Vitrasert) (September 28, 2004)
To read PDF, click here
From U.S. National Institutes of Health
- Valganciclovir: A New Treatment for Cytomegalovirus Retinitis (Winter 2002/2003)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- 2002 Safety Alert: Cytovene IV (Ganciclovir Sodium for Injection) (February 13, 2002)
From U.S. Food and Drug Administration
- Valganciclovir Recommended for Approval (April 2001)
In What's New, from Project Inform
- Advances in CMV Management: Fomivirsen (Vitravene®) Approved (December 1998)
In Project Inform Perspective, from Project Inform
- New CMV Retinitis Drug Approved (October 1998)
In Body Positive, from Body Positive
- Fomivirsen Approved for CMV Retinitis: First Antisense Drug (September 4, 1998)
From AIDS Treatment News
- Approval Letter for the Use of Vitravene Injection for the Local Treatment of Cytomegalovirus (CMV) Retinitis (August 28, 1998)
From U.S. Food and Drug Administration
- Better Treatment for CMV Retinitis: An Update (August 1998)
In HIV Newsline, from San Francisco General Hospital
- Improved Treatment of CMV Retinitis (February 1998)
In HIV Newsline, from San Francisco General Hospital
- CMV Viremia: A Look at the Other Viral Load (December 1997/January 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Improved Ganciclovir Regimens (December 1997/January 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- The Vitrasert Ganciclovir Implant's Place in the CMV Treatment Line Up (April/May 1997)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- The State of the Art: Treatment of CMV Disease (Spring 1997)
A comprehensive report.
In Direct Information on Research and Treatment Newsletter, from ARIC
- Cidofovir Warning (October 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Cidofovir Recommended for Approval for CMV Retinitis (April 5, 1996)
In AIDS Treatment News, from AIDS Treatment News
- New Developments in the Management of CMV Infections (April 1996)
In HIV Newsline, from San Francisco General Hospital
- CMV: The Other Virus (March 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- New Drug Recommended for Treament of CMV Retinitis (Spring 1996)
In STEP Perspective, from Seattle Treatment Education Project
- And Also, "Adefovir Dipovixil" (February 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Finding a Place for Cidofovir (January 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Oral Ganciclovir (Winter 1995)
In STEP Perspective, from Seattle Treatment Education Project
- Ganciclovir for CMV Retinitis (Summer 1995)
In STEP Perspective, from Seattle Treatment Education Project
- New Treatments, New Hope in Avoiding Blindness (June 1995)
From American Foundation for AIDS Research
Personal Accounts
Research
- CMV Levels May Predict HIV Disease Progression (October 2004)
Quick recap of a study in The Lancet.
In HIV Treatment ALERTS!, from The Center for AIDS
- HAART Good for Vision and Quality of Life, Studies Find (June 18, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- A Synergistic Effect of HIV and CMV Infection/Reactivation on Response to HAART and Plasma CD8+/CD38+ But Not CD4+ Cell Populations in Patients With Primary HIV Infection (July 10, 2002)
In The XIV International AIDS Conference, from The Body PRO
- Oral Valganciclovir as Effective as IV Ganciclovir in Treating CMV Retinitis in AIDS Patients (April 12, 2002)
Results of a recent Emory University study.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Discontinuation of Maintenance Therapy for Cytomegalovirus Retinitis in HIV-Infected Patients Who Have Responded to Highly Active Antiretroviral Therapy (December 18, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
- Needleless Retinitis Therapy with FDA Approval of Oral CMV Drug (April 2001)
In TAGline, from Treatment Action Group
- Advances in Treating CMV (August 2000)
In Project Inform Perspective, from Project Inform
- Long-Term Effects of HAART on Morbidity and Mortality in HIV-1-Infected Patients at Risk for CMV Disease (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Multicenter Evaluation of CMV Reactivation in HIV-infected Women at Potential Risk for CMV Disease (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Anti-HIV Treatment Improves Immune System and Fights Sight-Threatening Eye Infection (November 2, 1999)
From U.S. National Institutes of Health
- Update: Treatment of CMV Retinitis (October 1999)
In HIV Newsline, from San Francisco General Hospital
- A New Acronym, a New Threat: IRU (September 1999)
In Project Inform Perspective, from Project Inform
- Secondary Prophylaxis for CMV Retinitis (August 1999)
In HIV Newsline, from San Francisco General Hospital
- HIV-Related Clinical Updates: CMV/Cytomegalovirus Disease (May 2, 1998)
In The 8th Clinical Care Options for HIV Symposium, from The Body PRO
- Impact of Highly Active Antiretroviral Therapy on Opportunistic Infections (3 abstracts) (September 28-October 1, 1997)
In The 37th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- CMV Trials Struggle to Enroll (September 1997)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- CMV: Pathogenesis, Viral Load and Prophylaxis Treatment Strategies (June 1997)
In The 7th Annual Clinical Care Options for HIV Symposium, from The Body PRO
- CMV Retinitis, Newly Diagnosed: RS-79070 Trial (May 1, 1997)
From AIDS Treatment News
- CMV, RS-79070: Community Concern As Major Drug's Development Suspended (May 1, 1997)
From AIDS Treatment News
- Combination Drug Therapy for AIDS Found to Control Blinding Eye Infection (May 1997)
From U.S. National Institutes of Health
- Ganciclovir Prodrug Development Program Languishes While Roche Determines Market Demand (April/May 1997)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Treatment of CMV Retinitis (March 1997)
In Hopkins HIV Report, from Johns Hopkins AIDS Service
- CMV Retinitis Despite High CD4 Lymphocyte Counts (January 1997)
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Lobucavir (January 1997)
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- CPCRA v. Syntex (November 1996)
Effect of ddI on Ganciclovir may explain disparity between two prophylaxis studies.
From Treatment Action Group
- Cytomegalovirus: Report from the The Third International Conference on Drug Therapy in HIV Infection (November 1996)
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- Responding to CMV Neurologic Infections (November 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- CMV Information: Print, Online, Phone, Video (October 1996)
In AIDS Treatment News, from AIDS Treatment News
- CMV Retinitis Study Aborted (September 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Combination of Ganciclovir and Foscarnet Better than Monotherapy for Retinitis (April 1996)
In HIV Newsline, from San Francisco General Hospital
- Cytomegalovirus Retinitis: New Approaches (March 1996)
In Moore News for Care Providers, from Johns Hopkins AIDS Service
|
|
